Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantern Pharma Inc (NQ: LTRN )

3.260 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantern Pharma Inc

< Previous 1 2 3 Next >
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q2 2024
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024
LTRN stock results show that Lantern Pharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire
Keep an eye on machine learning stocks. With big demand, we could be looking at a half-trillion-dollar market by 2030. 
Via InvestorPlace
Recap: Lantern Pharma Q4 Earnings
Via Benzinga
Lantern Pharma Earnings Preview
Via Benzinga
Lantern Pharma: Q3 Earnings Insights
Via Benzinga
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
No AI category went down in February, but 3 did in March - confirming my comment last week that 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
A Preview Of Lantern Pharma's Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023
LTRN stock results show that Lantern Pharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. 
Via Benzinga
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Grand View Research says the global 
Via Talk Markets
3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom
Discover how these AI powerhouses are leveraging AI in the IT consulting, application software, and biotech industries. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI-Focused Drug Discovery Stocks Index Up 26% In December
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
The 3 Most Undervalued AI Penny Stocks to Buy in December
These AI penny stocks offer substantial returns to investors as the market continues to grow at a rapid pace. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
The 3 Most Undervalued Machine Learning Stocks to Buy in September 2023
Here are three machine-learning stocks that may be ready to move much higher when investor sentiment changes. 
Via InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.